Vaxcyte (PCVX) News Today $30.79 +0.02 (+0.06%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$30.78 0.00 (-0.02%) As of 08/29/2025 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PCVX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Rafferty Asset Management LLC Trims Holdings in Vaxcyte, Inc. $PCVX1 hour ago | marketbeat.comNorthern Trust Corp Sells 37,045 Shares of Vaxcyte, Inc. $PCVX3 hours ago | marketbeat.comWalleye Capital LLC Trims Stock Position in Vaxcyte, Inc. $PCVXAugust 29 at 5:20 AM | marketbeat.comComerica Bank Purchases 21,091 Shares of Vaxcyte, Inc. $PCVXAugust 28 at 6:56 AM | marketbeat.com100,100 Shares in Vaxcyte, Inc. $PCVX Acquired by Jump Financial LLCAugust 28 at 6:14 AM | marketbeat.comVaxcyte (NASDAQ:PCVX) Stock Price Down 4.9% - What's Next?August 27, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Trims Holdings in Vaxcyte, Inc. $PCVXAugust 27, 2025 | marketbeat.comVaxcyte, Inc. $PCVX Shares Sold by American Century Companies Inc.August 26, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Cuts Stock Position in Vaxcyte, Inc. $PCVXAugust 24, 2025 | marketbeat.comVaxcyte, Inc. $PCVX Shares Sold by Algert Global LLCAugust 24, 2025 | marketbeat.comWellington Management Group LLP Acquires 1,972,918 Shares of Vaxcyte, Inc. $PCVXAugust 22, 2025 | marketbeat.comAberdeen Group plc Grows Holdings in Vaxcyte, Inc. $PCVXAugust 22, 2025 | marketbeat.comRussell Investments Group Ltd. Has $7.54 Million Holdings in Vaxcyte, Inc. $PCVXAugust 22, 2025 | marketbeat.comNuveen LLC Invests $20.99 Million in Vaxcyte, Inc. $PCVXAugust 22, 2025 | marketbeat.comBrokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) Target Price at $136.50August 22, 2025 | americanbankingnews.comVaxcyte, Inc. (NASDAQ:PCVX) Receives Average Recommendation of "Buy" from AnalystsAugust 20, 2025 | marketbeat.comMizuho Securities Sticks to Its Buy Rating for Vaxcyte (PCVX)August 20, 2025 | theglobeandmail.comInvesco Ltd. Grows Stake in Vaxcyte, Inc. $PCVXAugust 19, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Cuts Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)August 18, 2025 | marketbeat.comFox Run Management L.L.C. Has $1.29 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)August 17, 2025 | marketbeat.comVanguard Group Inc. Increases Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)August 17, 2025 | marketbeat.comVaxcyte Inc.August 15, 2025 | barrons.comCaitong International Asset Management Co. Ltd Raises Position in Vaxcyte, Inc. (NASDAQ:PCVX)August 14, 2025 | marketbeat.comCitigroup Inc. Has $23.45 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)August 14, 2025 | marketbeat.comDeutsche Bank AG Trims Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)August 13, 2025 | marketbeat.comCantor Fitzgerald Reduces Earnings Estimates for VaxcyteAugust 11, 2025 | marketbeat.comLeerink Partnrs Has Bearish Estimate for Vaxcyte Q3 EarningsAugust 11, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Headlands Technologies LLCAugust 9, 2025 | marketbeat.comVaxcyte (NASDAQ:PCVX) Shares Gap Down Following Weak EarningsAugust 8, 2025 | marketbeat.comVaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-in-Class ...August 7, 2025 | finance.yahoo.comVaxcyte price target lowered to $50 from $85 at TD CowenAugust 7, 2025 | msn.comXTX Topco Ltd Boosts Stake in Vaxcyte, Inc. (NASDAQ:PCVX)August 7, 2025 | marketbeat.comVaxcyte (PCVX) Q2 Loss Widens 11%August 6, 2025 | fool.comVaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV)August 6, 2025 | globenewswire.comJ. Safra Sarasin Holding AG Acquires New Stake in Vaxcyte, Inc. (NASDAQ:PCVX)August 5, 2025 | marketbeat.comWestfield Capital Management Co. LP Has $81.38 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)August 4, 2025 | marketbeat.comAssetmark Inc. Acquires 13,648 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)August 3, 2025 | marketbeat.comVaxcyte, Inc. (PCVX)’s VAX-24 Achieves Phase 2 Success in InfantsJuly 31, 2025 | finance.yahoo.comVaxcyte, Inc. (PCVX)’s VAX-24 Achieves Phase 2 Success in InfantsJuly 31, 2025 | insidermonkey.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by TD Asset Management IncJuly 31, 2025 | marketbeat.comFiera Capital Corp Invests $13.56 Million in Vaxcyte, Inc. (NASDAQ:PCVX)July 30, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Acquires New Position in Vaxcyte, Inc. (NASDAQ:PCVX)July 30, 2025 | marketbeat.comVaxcyte (PCVX) Projected to Post Earnings on TuesdayJuly 29, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Stake Lifted by Envestnet Asset Management Inc.July 27, 2025 | marketbeat.comTeachers Retirement System of The State of Kentucky Acquires 6,929 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)July 26, 2025 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of "Buy" from AnalystsJuly 25, 2025 | marketbeat.comVictory Capital Management Inc. Has $8.34 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)July 25, 2025 | marketbeat.comNew York State Common Retirement Fund Increases Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)July 22, 2025 | marketbeat.comJennison Associates LLC Has $42.51 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)July 20, 2025 | marketbeat.comC WorldWide Group Holding A S Makes New $3.59 Million Investment in Vaxcyte, Inc. (NASDAQ:PCVX)July 18, 2025 | marketbeat.com Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PCVX Media Mentions By Week PCVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCVX News Sentiment▼1.461.09▲Average Medical News Sentiment PCVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCVX Articles This Week▼98▲PCVX Articles Average Week Get the Latest News and Ratings for PCVX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Vaxcyte and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Genmab A/S News Today Viatris News Today Dr. Reddy's Laboratories News Today Ascendis Pharma A/S News Today Qiagen News Today Moderna News Today Verona Pharma PLC American Depositary Share News Today BridgeBio Pharma News Today Elanco Animal Health News Today Roivant Sciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCVX) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PCVX Stock Alerts